Despite Cognizant cutting its guidance, Genpact has raised its revenue guidance for the full year led by an uptick in North America and its acquisition of Pharmalink earlier this year.
first published: Aug 20, 2014 05:59 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell
Live: Is Nifty likely to stay in profit-booking mode? | Opening Bell
Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more
How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns
